Copyright
©The Author(s) 2019.
World J Gastroenterol. Apr 21, 2019; 25(15): 1854-1864
Published online Apr 21, 2019. doi: 10.3748/wjg.v25.i15.1854
Published online Apr 21, 2019. doi: 10.3748/wjg.v25.i15.1854
Figure 3 The chemosensitization of Cycas revoluta Thunb.
natural extract with 5-fluorouracil. A: Clonogenic assays. The error bars represent ± STDEV from n = 3 independent experiments, bP < 0.01; B: Dose-response assays of 5-fluorouracil (5-Fu) with the extract; C: The half-maximal effective concentration and the half-maximal lethal concentration of 5-Fu in combination with the extract. The error bars represent ± STDEV from n = 3 independent experiments; D: Western blot analysis of drug-resistance-related proteins. GAPDH was used as a control. Relative expressions are shown in the left histogram, and the error bars represent ± STDEV from n = 3 independent experiments aP < 0.05, bP < 0.01. 5-Fu: 5-fluorouracil; EC50: Half-maximal effective concentration; LC50: Half-maximal lethal concentration; mTOR: Mammalian target of rapamycin; P-gp: P-glycoprotein.
- Citation: Cui XL, Li KJ, Ren HX, Zhang YJ, Liu XD, Bu BG, Wang L. Extract of Cycas revoluta Thunb. enhances the inhibitory effect of 5-fluorouracil on gastric cancer cells through the AKT-mTOR pathway. World J Gastroenterol 2019; 25(15): 1854-1864
- URL: https://www.wjgnet.com/1007-9327/full/v25/i15/1854.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i15.1854